Skip to content
zameds

Lercanidipine

Sold as Zanidip, Lercanidipine teva, Lercanidipine ivax, Lercanidipine pch, Lertens, Lerblok, Zercap, Lendidip, Nidexif, Trindip, Trinidip

S3Read from the PI-PIL document and verified
Loading the molecular structure
C36H41N3O6611.70 g/mol

5-O-[1-[3,3-Diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate

Drag to rotate. Structure from PubChem CID 65866.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
8
Registrations
20
Schedule source
SAHPRA documentation

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Pharmaplan (Pty) LtdCertificate held by Acino Pharma (Pty) LtdZanidip10, 20330113, A400106S3PIPIL
Teva Pharmaceuticals (Pty) LtdCancelledLercanidipine teva, Lercanidipine ivax, Lercanidipine pch10, 20460291, 460292, 460293, 460294, 460295, 460296S3None
Ranbaxy (SA) (Pty) LtdLertens10500638S3None
Ranbaxy Pharmaceutical (Pty) LtdLertens20500639S3None
Abex Pharmaceutica (Pty) LtdLerblok10, 20520384, 520385S3PIPIL
Macleods Pharmaceuticals SA (Pty) LtdCertificate held by Abex Pharmaceutica (Pty) LtdZercap10, 20520386.384, 520387S3PIPIL
Hetero Drugs South Africa (Pty) LtdLendidip, Nidexif10 mg, 20 mg570043, 570044, 570045.043, 570046.044S3None
Trinity Pharma (Pty) LtdTrindip, Trinidip10, 20570215, 570216S3None

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Zanidip 10

EACH TABLET CONTAINS LERCANIDIPINE HYDROCHLORIDE 10,0 mg

10Film-coated tablet.33011333/7.1/0113Approved 2 April 2025RegisteredS3PIPIL
Lercanidipine teva 10

EACH TABLET CONTAINS : LERCANIDIPINE HYDROCHLORIDE 10,0 mg

1046029146/7.1/0291CancelledS3None
Lercanidipine teva 20

EACH TABLET CONTAINS : LERCANIDIPINE HYDROCHLORIDE 20,0 mg

2046029246/7.1/0292CancelledS3None
Lercanidipine ivax 10

EACH TABLET CONTAINS : LERCANIDIPINE HYDROCHLORIDE 10,0 mg

1046029346/7.1/0293CancelledS3None
Lercanidipine ivax 20

EACH TABLET CONTAINS : LERCANIDIPINE HYDROCHLORIDE 20,0 mg

2046029446/7.1/0294CancelledS3None
Lercanidipine pch 10

EACH TABLET CONTAINS : LERCANIDIPINE HYDROCHLORIDE 10,0 mg

1046029546/7.1/0295CancelledS3None
Lercanidipine pch 20

EACH TABLET CONTAINS : LERCANIDIPINE HYDROCHLORIDE 20,0 mg

2046029646/7.1/0296CancelledS3None
Lertens 10

EACH TABLET CONTAINS: LERCANIDIPINE HYDROCHLORIDE 10,0 mg

1050063850/7.1/0638RegisteredS3None
Lertens 20

EACH TABLET CONTAINS: LERCANIDIPINE HYDROCHLORIDE 20,0 mg

2050063950/7.1/0639RegisteredS3None
Lerblok 10

EACH TABLET CONTAINS: LERCANIDIPINE HYDROCHLORIDE 10,0 mg

10Film-coated tablets52038452/7.1/0384Approved 21 August 2021RegisteredS3PIPIL
Lerblok 20

EACH TABLET CONTAINS: LERCANIDIPINE HYDROCHLORIDE 20,0 mg

20Film-coated tablets52038552/7.1/0385Approved 21 August 2021RegisteredS3PIPIL
Zercap 1010Film-coated tablets520386.38452/7.1/0386Approved 21 August 2021RegisteredS3PIPIL
Zercap 2020Film-coated tablets52038752/7.1/0387.385Approved 21 August 2021RegisteredS3PIPIL
Lendidip 10 MG

Each Tablet contains: Lercanidipine Hydrochloride equivalent to Lercanidipine 10,0 mg

10 mg57004357/7.1/0043RegisteredS3None
Lendidip 20 MG

Each Tablet contains: Lercanidipine Hydrochloride 20,0 mg

20 mg57004457/7.1/0044RegisteredS3None
Nidexif 10 MG

Each Tablet contains: Lercanidipine Hydrochloride 10 mg

10 mg570045.04357/7.1/0045.043RegisteredS3None
Nidexif 20 MG

Each Tablet contains: Lercanidipine Hydrochloride equivalent to Lercanidipine 20,0 mg

20 mg570046.04457/7.1/0046.0044RegisteredS3None
Trindip 10

Each Tablet contains: Lercanidipine Hydrochloride equivalent to Lercanidipine 10,0 mg

1057021557/7.1/0215RegisteredS3None
Trinidip 20

Each Tablet contains: Lercanidipine Hydrochloride equivalent to Lercanidipine 20,0 mg

2057021657/7.1/0216RegisteredS3None
Zanidip 20

EACH TABLET CONTAINS LERCANIDIPINE HYDROCHLORIDE 10,0 mg

20Film-coated tablet.A400106A40/7.1/0106Approved 2 April 2025RegisteredS3PIPIL

Regulatory status

Where S3 sits on the scale

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, read from the product's PI-PIL leaflet.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Lercanidipine hydrochloride

  • S3: Lercanidipine

    Consolidated Schedules 06 July 2026, line 3876

Pharmacological class: Vasodilators, hypotensive, antihypertensive medicines include other antihypertensive medicines e.g. ACE-inhibitors, ARBs, RAAS, etc] (class 7.1)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

Zanidip 10, Pharmaplan (Pty) Ltd is scheduled S3 in its official SAHPRA documents, read with 90% confidence.

Professional information (PI)For healthcare professionalsZanidip 10, Pharmaplan (Pty) LtdPatient information leaflet (PIL)For patients and carersZanidip 10, Pharmaplan (Pty) Ltd

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Research articles

Loading...
Loading PubMed articles